Overview

Breaking news

67 MSEK IN NEW FUNDING

We are pleased to announce that we have raised 67 MSEK in a new share issue led by Sciety.

Read more →

THE CTA IS SUBMITTED

The Clinical Trial Application (CTA) has been submitted to the MPA

Read more →

CTC AWARDED AS CRO

It is with pleasure that we can announce that Clinical Trial Consultants AB (CTC)

Read more →

CANADA PATENT GRANT

We are pleased to announce that PharmNovo AB has been granted a patent for our candidate PN6047 in Canada. Previously patent has been granted in the USA, the EU, Japan, Australia and China. Canada was the last major country remaining for PN6047.

Read more →

MEET OUR CMO

PharmNovo is pleased to announce the appointment of Olof Breuer MD, PhD, Specialist in Clinical Pharmacology, who will be acting as our Chief medical officer. Olof has over 25 years of experience in Pharmaceutical R&D, where of 17 years within big and small pharmaceutical companies.

Read more →

Find us

PharmNovo AB
Medicon Village AB
Scheeletorget 1
SE-223 81 Lund, Sweden

Map